-
1 Comment
CCM Duopharma Biotech Berhad is currently in a long term downtrend where the price is trading 12.9% below its 200 day moving average.
From a valuation standpoint, the stock is 45.5% cheaper than other stocks from the Other sector with a price to sales ratio of 3.5.
CCM Duopharma Biotech Berhad's total revenue sank by 6.4% to $134M since the same quarter in the previous year.
Its net income has dropped by 4.9% to $14M since the same quarter in the previous year.
Finally, its free cash flow grew by 503.0% to $6M since the same quarter in the previous year.
Based on the above factors, CCM Duopharma Biotech Berhad gets an overall score of 2/5.
| CurrencyCode | MYR |
|---|---|
| Exchange | KLSE |
| ISIN | MYL7148OO009 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 1B |
|---|---|
| PE Ratio | 18.0 |
| Target Price | 1.502 |
| Dividend Yield | 2.4% |
| Beta | 0.73 |
Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products comprising vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides specialty pharmaceutical drugs for targeted conditions, biosimilar products, and medical devices and consumables to patients with conditions, such as diabetes, cancer, cardiovascular diseases, renal diseases, and others. The company's product portfolio comprises covasc, crystorvas, and vytocor; lebreta, and krabeva; and unihepa, erysaa, bi-haemosol, and haemosol. Additionally, it offers its products under the Champs, Flavettes, Eye Glo, Proviton, Naturalle, IRORO Nutreatment, and Uphamol brands. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. Duopharma Biotech Berhad was founded in 1978 and is headquartered in Kuala Lumpur, Malaysia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7148.KLSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
